Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
PaperCitations, authors & open-access status
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 352 citations, 2016 year and closed oa status.
352
Citations
2016
Year
closed
OA Status